Effect of Shuxinyin (舒心饮) on In-Stent Restenosis after Coronary Artery Stenting

Objective: To evaluate the effect of anti-platelet regimens and it's combination with Shuxinyin (SXY, 舒心饮,) on in-stent restenosis after stent implantation. Methods: Forty-four patients with successful stent implantation in a coronary artery were randomly assigned to the treated group (n=20) and the control group (n=24). The treated group received: SXY and anti-platelet therapy. The control group were treated with anti-platelet regimens only. Platelet activation was assessed before and immediately after the stenting by flow cytometry, the expression of P-selectin (CD62P) and glycoprotein(GP) Ⅱb/Ⅲa receptor. It was reassessed on the 30th day after stenting. Plasma fibrinogen (Fg) and C-reaction protein (CRP) were measured by biuret and laser scattering turbidimetry respectively at the same time. Observation was made on the scoring of the symptoms of Qi deficiency syndrome, Qi-Yin deficiency syndrome and blood stasis syndrome in the two groups. Differences between groups were compared. Results: Compared with the control group, combination with SXY and anti-platelet therapy was remarkable in reducing plasma CRP (P<0.05), and also with the tendency to decrease plasma Fg, GPⅡb/Ⅲa and CD62P. It could also evidently decrease the scoring of Qi-Yin deficiency syndrome, Qi deficiency syndrome and blood stasis syndrome after stenting (P<0.05, 0.01, 0.01) respectively. Follow-up survey found 40% relapse of angina pectoris with 4 cases of in-stent restenosis proved by angiography in the treated group. But the relapse of angina pectoris in the control group was 67% with 2 cases of myocardial infarction (MI), 7 cases of in-stent restenosis proved by angiography and one death. Conclusions: Combination with SXY and anti-platelet regimens can prevent stent thrombosis and in-stent restenosis after stent implantation, and it seems superior to anti-platelet therapy only.     

测定碘盐中碘的紫外分光光度法

碘盐中碘含量的测定方法目前仍以碘量法为主。为克服碘量法灵敏度低的缺点,我们以碘量法为基础,把生成物碘作为标准设计了测定碘含量的紫外或近紫外分光光度法。经试验结果准确可靠,方法简单易行。现介绍如下:     

活力甦口服液

欢迎您:请使用抗衰老新药——延年益寿,永保青春,是人类美好的幻想:增强活力,推迟衰老,是目前现实的可能活力甦是根据宋代(和剂局方)何首乌丸,明代(证治准绳)枸杞丸等古代名方,经著名老中医长期临床实验,加减化裁,根据中医理论对机体衰退的认识,应用现代科学技术手段,科学组方,研制而成。是目前国内较好的一种抗衰老中药制剂。[主要成份]何首乌、黄芪、黄精、枸杞子、丹参等。[基础研究]1.生物化学及兔疲功能测定:根据衰老的自由基和免疫学理论,通过对200余例中老年观察对象血中抗氧化酶类活性(超氧     

针刺结合中药治疗男性免疫性不育的疗效观察

目的观察针刺结合归肾丸治疗男性免疫性不育症的临床疗效。方法对106例免疫性不孕患者采用分组对照方法治疗。其中针刺结合归肾丸治疗组40例，归肾丸治疗组46例，强的松治疗对照组20例。结果针刺结合归肾丸治疗组总有效率为92．50％，归肾丸治疗组为89．13％，强的松治疗对照组为70．00％。结论针刺结合归肾丸通过补益肾气、滋养肾阴、改善机体的免疫功能，治疗男性免疫性不育症有确切疗效。     

中医护理技术应用于神经根型颈椎病治疗的研究进展

心房颤动在临床较为常见,目前射频消融治疗心房颤动作为临床的一线治疗。但是即使患者行射频消融术治疗心房颤动,仍有可能复发,心房颤动的持续会严重影响患者生活质量,如何更好地降低心房颤动消融后的复发率及改善患者的预后,提高患者的生活质量,是临床中需要解决的问题。螺内酯联合胺碘酮被认为是一种有效、安全的控制心房颤动患者窦性心律的方案,本文对胺碘酮和螺内酯及两者联用对预防心房颤动射频融术后复发的临床相关研究予以综述。     

大环内酯类抗生素的不良反应概况

大环内酯类抗生素(macrolides)是一类化学结构和抗菌作用相似的抗菌药物。按其大环结构含碳母核的不同，可分为14、15、16元环大环内酯类抗生素。50年代14元环的红霉素因对革兰阳性菌抗菌作用强，对治疗社会获得性呼吸道感染、皮肤软组织感染等具有良好疗效，而广泛应用于临床。世界药学工作者陆续研制开发了对酸稳定的第二代大环内酯类抗生素，改善了抗耐药性，扩展了抗菌谱，增强了抗菌活性，     

舒心饮对气阴两虚型冠心病患者血浆肾素-血管紧张素系统的影响

采用放射免疫法观察冠心病气阴两虚型患者服用费心饮治疗前后血肾素（PRA）、血管紧张素Ⅱ（AngⅡ）的变化，并以开搏通为对照组。结果发现舒心饮能显著降低AngⅡ（P＜0．01），对临床症状和体征的总有效率为87%。提示舒心饮可能通过抑制肾素-血管紧张素系统（R－A－S）而发挥治疗作用。     

肝素在儿科中的应用

目的介绍肝素在儿科的临床应用。方法参阅相关文献,进行综合、分析和归纳。结果肝素在治疗小儿支气管和肺部疾病、新生儿硬肿症、过敏性紫癫、危重儿伴全身炎症反应综合征、危重患儿弥散性血管内凝血、胎儿宫内发育迟缓和婴儿巨细胞病毒肝炎等疾病方面有显著疗效,且不良反应少。结论肝素在儿科临床上具有广阔的应用前景。